Uric acid enhances neurogenesis in a parkinsonian model by remodeling mitochondria
GoodRx is not available outside of the United States and therefore, access to the site is blocked
Current Evidence and Clinical Trial Findings Phase 2 data published in the NEJM (2023) showed dose-dependent body weight reductions with retatrutide over 48 weeks, with gastrointestinal side effects being the most commonly reported
Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan
However, the exact mechanism behind how GLP-1 medications may reduce Alzheimer's risk is unknown so more research is needed, according to Xu
You may need to change your semaglutide dose or temporarily stop taking this medication in certain situations that can result in changes in blood glucose levels, for example, changes in diet and exercise, infections, illnesses, injuries, or emotional stress